Literature DB >> 27821486

Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer.

Agnieszka A Rucki1,2,3, Kelly Foley1,2,3, Pingbo Zhang4, Qian Xiao1,2, Jennifer Kleponis1,2, Annie A Wu1,2, Rajni Sharma5, Guanglan Mo1,2,6, Angen Liu1, Jennifer Van Eyk7, Elizabeth M Jaffee1,2,3,5,6,8, Lei Zheng9,2,3,6,8.   

Abstract

Understanding how stromal signals regulate the development of pancreatic ductal adenocarcinoma (PDAC) may suggest novel therapeutic interventions in this disease. In this study, we assessed the metastatic role of stromal signals suggested to be important in the PDAC microenvironment. Src and IGF-1R phosphorylated the prometastatic molecule Annexin A2 (AnxA2) at Y23 and Y333 in response to stromal signals HGF and IGF-1, respectively, and IGF-1 expression was regulated by the Sonic Hedgehog (Shh) pathway. Both Shh and HGF were heterogeneously expressed in PDAC stroma, and only dual inhibition of these pathways could significantly suppress AnxA2 phosphorylation, PDAC growth, and metastasis. Taken together, our results illuminate tumor-stromal interactions, which drive metastasis, and provide a mechanism-based rationale for a stroma-directed therapy for PDAC. Cancer Res; 77(1); 41-52. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27821486      PMCID: PMC5245778          DOI: 10.1158/0008-5472.CAN-16-1383

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

Review 1.  Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.

Authors:  Agnieszka Anna Rucki; Lei Zheng
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

2.  Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist.

Authors:  Shifeng Pan; Xu Wu; Jiqing Jiang; Wenqi Gao; Yongqin Wan; Dai Cheng; Dong Han; Jun Liu; Nathan P Englund; Yan Wang; Stefan Peukert; Karen Miller-Moslin; Jing Yuan; Ribo Guo; Melissa Matsumoto; Anthony Vattay; Yun Jiang; Jeffrey Tsao; Fangxian Sun; AnneMarie C Pferdekamper; Stephanie Dodd; Tove Tuntland; Wieslawa Maniara; Joseph F Kelleher; Yung-Mae Yao; Markus Warmuth; Juliet Williams; Marion Dorsch
Journal:  ACS Med Chem Lett       Date:  2010-03-16       Impact factor: 4.345

Review 3.  A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490.

Authors:  Julio R Caceres-Cortes
Journal:  Anticancer Agents Med Chem       Date:  2008-10       Impact factor: 2.505

Review 4.  Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.

Authors:  Suzie J Scales; Frederic J de Sauvage
Journal:  Trends Pharmacol Sci       Date:  2009-05-13       Impact factor: 14.819

Review 5.  Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Michael Steinberg
Journal:  Clin Ther       Date:  2007-11       Impact factor: 3.393

6.  Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.

Authors:  T H Corbett; B J Roberts; W R Leopold; J C Peckham; L J Wilkoff; D P Griswold; F M Schabel
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

7.  Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin Activation.

Authors:  Marjo de Graauw; Ine Tijdens; Mirjam B Smeets; Paul J Hensbergen; André M Deelder; Bob van de Water
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

8.  Effect of tyrosine mutations on the kinase activity and transforming potential of an oncogenic human insulin-like growth factor I receptor.

Authors:  Y Jiang; J L Chan; C S Zong; L H Wang
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

9.  GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy.

Authors:  Yu Xue; Jian Ren; Xinjiao Gao; Changjiang Jin; Longping Wen; Xuebiao Yao
Journal:  Mol Cell Proteomics       Date:  2008-05-06       Impact factor: 5.911

10.  RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas.

Authors:  Maciej Tarnowski; Gabriela Schneider; Gabriele Amann; Geoffrey Clark; Peter Houghton; Frederic G Barr; Lukas Kenner; Mariusz Z Ratajczak; Magda Kucia
Journal:  Int J Oncol       Date:  2012-06-28       Impact factor: 5.650

View more
  38 in total

1.  Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition.

Authors:  Imran Siddiqui; Marco Erreni; Mohammad Azhar Kamal; Chiara Porta; Federica Marchesi; Samantha Pesce; Fabio Pasqualini; Silvia Schiarea; Chiara Chiabrando; Alberto Mantovani; Paola Allavena
Journal:  Oncoimmunology       Date:  2017-11-01       Impact factor: 8.110

2.  Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer.

Authors:  Andrew E Shouksmith; Fenil Shah; Michelle L Grimard; Justyna M Gawel; Yasir S Raouf; Mulu Geletu; Angelika Berger-Becvar; Elvin D de Araujo; H Artee Luchman; William L Heaton; David Bakhshinyan; Ashley A Adile; Chitra Venugopal; Thomas O'Hare; Michael W Deininger; Sheila K Singh; Stephen F Konieczny; Samuel Weiss; Melissa L Fishel; Patrick T Gunning
Journal:  J Med Chem       Date:  2019-03-06       Impact factor: 7.446

3.  Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer.

Authors:  Alex B Blair; Victoria M Kim; Stephen T Muth; May Tun Saung; Nathalie Lokker; Barbara Blouw; Todd D Armstrong; Elizabeth M Jaffee; Takahiro Tsujikawa; Lisa M Coussens; Jin He; Richard A Burkhart; Christopher L Wolfgang; Lei Zheng
Journal:  Clin Cancer Res       Date:  2019-06-11       Impact factor: 12.531

4.  Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development.

Authors:  Nina J Chu; Robert A Anders; Elana J Fertig; Minwei Cao; Alexander C Hopkins; Bridget P Keenan; Aleksandra Popovic; Todd D Armstrong; Elizabeth M Jaffee; Jacquelyn W Zimmerman
Journal:  Cancer Prev Res (Phila)       Date:  2020-05-14

Review 5.  Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve.

Authors:  Noelle Jurcak; Lei Zheng
Journal:  Pharmacol Ther       Date:  2019-04-29       Impact factor: 12.310

Review 6.  Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.

Authors:  Alex B Blair; Adrian Murphy
Journal:  Curr Probl Cancer       Date:  2017-10-31       Impact factor: 3.187

Review 7.  Annexin Animal Models-From Fundamental Principles to Translational Research.

Authors:  Thomas Grewal; Carles Rentero; Carlos Enrich; Mohamed Wahba; Carsten A Raabe; Ursula Rescher
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

8.  Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment.

Authors:  Agnieszka A Rucki; Qian Xiao; Stephen Muth; Jianlin Chen; Xu Che; Jennifer Kleponis; Rajni Sharma; Robert A Anders; Elizabeth M Jaffee; Lei Zheng
Journal:  Mol Cancer Ther       Date:  2017-09-01       Impact factor: 6.261

9.  Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Chunxia Du; Annacarolina da Silva; Vicente Morales-Oyarvide; Brian M Wolpin; Jonathan A Nowak; Andressa Dias Costa; Margaret M Kozak; Richard F Dunne; Douglas A Rubinson; Kimberly Perez; Yohei Masugi; Tsuyoshi Hamada; Lauren K Brais; Chen Yuan; Ana Babic; Matthew D Ducar; Aaron R Thorner; Andrew Aguirre; Matthew H Kulke; Kimmie Ng; Thomas E Clancy; Jennifer J Findeis-Hosey; Daniel T Chang; Jason L Hornick; Charles S Fuchs; Shuji Ogino; Albert C Koong; Aram F Hezel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

10.  Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma.

Authors:  Robert J Torphy; Zhen Wang; Aisha True-Yasaki; Keith E Volmar; Naim Rashid; Benjamin Yeh; Judy M Anderson; Julia S Johansen; Michael A Hollingsworth; Jen Jen Yeh; Eric A Collisson
Journal:  JCO Precis Oncol       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.